Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1356334A details novel Ru-H4-BINAP complexes for efficient ketone reduction, offering high ee values and scalable routes for chiral alcohol intermediates.
Patent CN1356334A reveals novel Ru-H4-BINAP-diamine catalysts enabling high-ee asymmetric hydrogenation of ketones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Advanced asymmetric hydrogenation patent CN103232324B enables cost-effective production of chiral pharmaceutical intermediates with high conversion rates.
Patent CN102040625B discloses efficient chiral spiro ligands for iridium-catalyzed asymmetric hydrogenation, offering high enantioselectivity and low catalyst loading for pharmaceutical manufacturing.
Discover the advanced enantioselective process for HMG-CoA inhibitors described in CN1636004A. Achieve high purity statin intermediates with reduced waste and scalable catalytic methods.
Patent CN1636004A details a novel asymmetric transfer hydrogenation route for HMG-CoA inhibitors. Achieve high purity statin intermediates with reduced waste and scalable manufacturing processes.
Patent CN111410604B details iridium-catalyzed asymmetric hydrogenation of enenoic acids, offering a direct route to chiral intermediates with high enantioselectivity and reduced processing steps.
Patent CN110655456A introduces a cobalt-catalyzed method for asymmetric hydrogenation of mixed E/Z olefins. Achieves high enantioselectivity for pharmaceutical intermediates with significant cost advantages.
Patent CN102119165A introduces stable chiral iridium catalysts for asymmetric transfer hydrogenation in water, offering safer and greener pharmaceutical intermediate manufacturing.
Novel aqueous chiral iridium catalyst enables safe, high-yield asymmetric transfer hydrogenation for pharmaceutical intermediates with superior stability.
Patent CN101090770B discloses a dual-ligand Rh-catalyzed system for asymmetric hydrogenation, delivering superior enantioselectivity and cost efficiency for API manufacturing.
Patent CN117820257B reveals a novel chiral hydrogenation method for pinaverium bromide intermediates, ensuring high purity and scalable supply chain reliability.
Patent CN107417724B reveals a novel Ru-SPO catalyst achieving 99% selectivity. Discover cost-effective solutions for chiral pharmaceutical intermediate manufacturing.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN106086089B details enzymatic route for high purity (R)-citronellal. Offers green manufacturing and supply chain stability for global fragrance and pharma intermediates.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.
Patent CN1119332C details a novel asymmetric hydrogenation route for azepine intermediates, offering cost-effective and scalable production for kinase inhibitors like Balanol.
Patent CN101675020A details a novel asymmetric hydrogenation method for high-purity optically active aldehydes like citronellal, offering enhanced catalyst stability and supply chain reliability.
Patent CN1761642A details an efficient asymmetric hydrogenation process for chiral beta-amino acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN117050081A reveals a novel four-step synthesis route for moxifloxacin side chains offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.